Skip to Content

iShares US Pharmaceuticals ETF IHE

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IHE

Will IHE outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

iShares US Pharmaceuticals ETF earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IHE

  • Current Portfolio Date
  • Equity Holdings 34
  • Bond Holdings 0
  • Other Holdings 4
  • % Assets in Top 10 Holdings 81.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
23.76
84,737,948
Healthcare
23.26
82,985,613
Healthcare
4.69
16,718,664
Healthcare
4.66
16,631,994
Healthcare
4.64
16,546,792
Healthcare
4.47
15,937,338
Healthcare
4.46
15,895,814
Healthcare
4.41
15,725,002
Healthcare
3.53
12,593,555
Healthcare
3.52
12,544,378
Healthcare